The brain drain to the US is a major obstacle to the growth of the European Biotechnology sector.  Many governmental and EU agencies have attempted to tackle this dilemma with limited success.EuroBack provides a unique and revolutionary solution to this problem.

By offering an unbiased assessment of the situation within Europe and access to funding, expertise and networking opportunities - together with a personalised and fully integrated service dedicated to easing the transition and contributing to its success - EuroBack will facilitate the economic growth of the biotech biopoles within the European Union.